“Molecular docking and dynamics analysis to reveal the therapeutic potential of Dostarlimab against novel immune targets in liver cancer”, IJBB, vol. 61, no. 11, pp. 740–755, Oct. 2024, doi: 10.56042/ijbb.v61i11.12051.